Tuberculosis-related serpiginous choroiditis: aggressive therapy with dual concomitant combination of multiple anti-tubercular and multiple immunosuppressive agents is needed to halt the progression of the disease.
J Ophthalmic Inflamm Infect
; 12(1): 7, 2022 Feb 08.
Article
in En
| MEDLINE
| ID: mdl-35132499
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Ophthalmic Inflamm Infect
Year:
2022
Document type:
Article
Affiliation country:
Switzerland